Bulletin
Investor Alert

Protagonist Therapeutics Inc.

NAS: PTGX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 3, 2021, 7:18 p.m.

/zigman2/quotes/205674595/composite

$

32.27

Change

0.00 0.00%

Volume

Volume 9,465

Quotes are delayed by 20 min

/zigman2/quotes/205674595/composite

Previous close

$ 32.69

$ 32.27

Change

-0.42 -1.28%

Day low

Day high

$31.79

$33.17

Open

52 week low

52 week high

$12.80

$50.54

Open

Insider Actions for Protagonist Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/21/2021 Dinesh V. Patel
President and CEO; Director
40,000   Derivative/Non-derivative trans. at $4.21 per share. 168,400
08/17/2021 David Y. Liu
Chief Scientific Officer
14,779   Disposition at $47.56 per share. 702,889
08/17/2021 David Y. Liu
Chief Scientific Officer
10,000   Derivative/Non-derivative trans. at $0.87 per share. 8,700
02/26/2021 Dinesh V. Patel
President and CEO; Director
25,000   Award at $0 per share. 0
02/26/2021 Suneel Gupta
Chief Development Officer
12,000   Award at $0 per share. 0
02/26/2021 David Y. Liu
Chief Scientific Officer
10,000   Award at $0 per share. 0
02/26/2021 Samuel R. Saks
Chief Medical Officer
12,000   Award at $0 per share. 0
02/26/2021 Donald A. Kalkofen
Chief Financial Officer
7,500   Award at $0 per share. 0
02/11/2021 Sarah B. Noonberg
Director
3,700   Disposition at $25.09 per share. 92,833
02/11/2021 Sarah B. Noonberg
Director
3,700   Award at $6.98 per share. 25,826
02/10/2021 Sarah B. Noonberg
Director
400   Disposition at $26.04 per share. 10,416
02/10/2021 Sarah B. Noonberg
Director
4,300   Disposition at $25.42 per share. 109,306
02/10/2021 Sarah B. Noonberg
Director
4,700   Award at $6.98 per share. 32,806
01/19/2021 Dinesh V. Patel
President and CEO; Director
24,846   Disposition at $24.6 per share. 611,211
01/19/2021 Dinesh V. Patel
President and CEO; Director
13,000   Derivative/Non-derivative trans. at $4.21 per share. 54,730
08/11/2020 Chaitan S. Khosla
Director
2,499   Disposition at $17.19 per share. 42,957
08/11/2020 Chaitan S. Khosla
Director
2,499   Derivative/Non-derivative trans. at $1.89 per share. 4,723
04/29/2020 Dinesh V. Patel
President and CEO; Director
2,000   Gift at $0 per share. 0
03/20/2020 Dinesh V. Patel
President and CEO; Director
10,000   Derivative/Non-derivative trans. at $1.89 per share. 18,900
03/12/2020 Dinesh V. Patel
President and CEO; Director
18,344   Derivative/Non-derivative trans. at $1.16 per share. 21,279
03/12/2020 Harold E. Selick
Director
12,000   Acquisition at $6.7 per share. 80,400

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
0 Sales
40,000
0
Last 6 months
2 Purchases
1 Sales
50,000
14,779
Last 12 months
10 Purchases
5 Sales
137,900
48,025

Officers and Executives

Dr. Dinesh V. Patel
President, Chief Executive Officer & Director
Mr. Donald A. Kalkofen
Chief Financial Officer
Dr. Paula O’Connor
Senior Vice President-Clinical Development
Dr. Mark L. Smythe
Vice President-Technology
Dr. David Y. Liu
Chief Scientific Officer
Dr. Samuel R. Saks
Chief Medical Officer
Ms. Tracy M. Woody
Executive Vice President-Corporate Strategy
Dr. Scott Plevy
Executive Vice President & Head-Gastroenterology
Dr. Ashok Bhandari
Senior Director-Chemistry
Mr. Carter J. King
Vice President-Business Development
Dr. Suneel Gupta
Chief Development Officer
Ms. Carena Spivey
Executive Director-Human Resources
Mr. Matthew M. Gosling
Executive Vice President & General Counsel
Dr. Harold E. Selick
Chairman
Ms. Sarah A. O'Dowd
Independent Director
Mr. William D. Waddill
Independent Director
Dr. Lewis T. Williams
Independent Director
Dr. Sarah B. Noonberg
Independent Director
Mr. Bryan Giraudo
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.